1. Home
  2. VYGR vs PROF Comparison

VYGR vs PROF Comparison

Compare VYGR & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • PROF
  • Stock Information
  • Founded
  • VYGR 2013
  • PROF N/A
  • Country
  • VYGR United States
  • PROF Canada
  • Employees
  • VYGR N/A
  • PROF N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • PROF Medical/Dental Instruments
  • Sector
  • VYGR Health Care
  • PROF Health Care
  • Exchange
  • VYGR Nasdaq
  • PROF Nasdaq
  • Market Cap
  • VYGR 172.6M
  • PROF 149.7M
  • IPO Year
  • VYGR 2015
  • PROF N/A
  • Fundamental
  • Price
  • VYGR $3.19
  • PROF $5.55
  • Analyst Decision
  • VYGR Strong Buy
  • PROF Strong Buy
  • Analyst Count
  • VYGR 8
  • PROF 1
  • Target Price
  • VYGR $14.33
  • PROF $11.00
  • AVG Volume (30 Days)
  • VYGR 647.7K
  • PROF 31.9K
  • Earning Date
  • VYGR 08-12-2025
  • PROF 08-14-2025
  • Dividend Yield
  • VYGR N/A
  • PROF N/A
  • EPS Growth
  • VYGR N/A
  • PROF N/A
  • EPS
  • VYGR N/A
  • PROF N/A
  • Revenue
  • VYGR $66,958,000.00
  • PROF $11,862,000.00
  • Revenue This Year
  • VYGR N/A
  • PROF $71.17
  • Revenue Next Year
  • VYGR $78.89
  • PROF $134.25
  • P/E Ratio
  • VYGR N/A
  • PROF N/A
  • Revenue Growth
  • VYGR N/A
  • PROF 75.01
  • 52 Week Low
  • VYGR $2.65
  • PROF $3.90
  • 52 Week High
  • VYGR $9.55
  • PROF $10.71
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 48.20
  • PROF 43.22
  • Support Level
  • VYGR $3.15
  • PROF $5.40
  • Resistance Level
  • VYGR $3.79
  • PROF $6.04
  • Average True Range (ATR)
  • VYGR 0.21
  • PROF 0.25
  • MACD
  • VYGR 0.00
  • PROF -0.03
  • Stochastic Oscillator
  • VYGR 16.67
  • PROF 23.20

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: